Evaluation of the clinical safety of desmopressin during pregnancy in women with a low plasmatic von Willebrand factor level and bleeding history

Thromb Res. 2007;120(3):387-90. doi: 10.1016/j.thromres.2006.09.004. Epub 2006 Oct 20.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Blood Coagulation Disorders / diagnosis*
  • Blood Coagulation Disorders / prevention & control
  • Cohort Studies
  • Deamino Arginine Vasopressin / adverse effects
  • Deamino Arginine Vasopressin / therapeutic use*
  • Drug Evaluation
  • Factor VIII / metabolism
  • Female
  • Hemostatics / adverse effects
  • Hemostatics / therapeutic use*
  • Humans
  • Pregnancy
  • Pregnancy Complications, Cardiovascular*
  • Pregnancy Outcome
  • Pregnancy Trimester, Third
  • Retrospective Studies
  • von Willebrand Factor / genetics*
  • von Willebrand Factor / metabolism*

Substances

  • Hemostatics
  • von Willebrand Factor
  • Factor VIII
  • Deamino Arginine Vasopressin